André Felipe Berto De Almada
André Felipe Berto De Almada has a total of 23 co-authors. Here are the top co-authors by number of shared publications:
- Daniela Dib Gonçalves
Graduate Program in Animal Science with Emphasis on Bioactive Products, Universidade Paranaense, Umuarama 87502-210, Brazil
3 shared publications - Ranulfo Piau Junior
Universidade Paranaense, Brazil
2 shared publications - Adalberto Ramom Valderrama Gerbasi
Universidade Autônoma de Barcelona
1 shared publication - Eduardo Herrera Dias
Universidade Paranaense,UNIPAR, Umuarama, PR, Brasil
1 shared publication - G.C. Gimenes
Ágora Clínica Veterinária, Brazil
1 shared publication - G.L. Bastos
Universidade Paranaense, Brazil
1 shared publication
Latest Publications
- Open Access
- 1 July 2023
- Published by Uniao Atlantica de Pesquisadores in Concilium
- Vol. 23 (14) , 222-234
Probiotics and prebiotics in dairy farming
The search for natural products that favor productive performance in animal feed has been gaining strength with probiotics, prebiotics and symbiotics that constitute an alternative for mastitis control. The action of these products is in the competition with unwanted microorganisms, stimulating the beneficial microbiota, in addition to favoring a greater development in the intestinal villi, which can provide a better absorption of nutrients. These compounds are an alternative to treatment with antibiotics that have caused the emergence of resistant microorganisms, in addition to causing sensory changes in milk and its derivatives. Through this study, it was possible to verify the importance of this class of substance for dairy farming and for unique health in general.
- 1 July 2023
- Published by Uniao Atlantica de Pesquisadores in Concilium
- Vol. 23 (14) , 222-234
Open AccessProbiotics and prebiotics in dairy farming
The search for natural products that favor productive performance in animal feed has been gaining strength with probiotics, prebiotics and symbiotics that constitute an alternative for mastitis control. The action of these products is in the competition with unwanted microorganisms, stimulating the beneficial microbiota, in addition to favoring a greater development in the intestinal villi, which can provide a better absorption of nutrients. These compounds are an alternative to treatment with antibiotics that have caused the emergence of resistant microorganisms, in addition to causing sensory changes in milk and its derivatives. Through this study, it was possible to verify the importance of this class of substance for dairy farming and for unique health in general.
- Open Access
- 17 September 2020
- Published by Research, Society and Development in Research, Society and Development
- Vol. 9 (10)
Bacteriophages’ action against mastitis-causing bactéria
Mastitis is a breast tissue disease with a high incidence in dairy cows and implications ranging from the health of the animals to the economy of the sector. Although antibiotic therapy is widely used, the search for new perspectives in the management and treatment of this disease is necessary. Although phage research preceded the discovery of antibiotics, with the appearance of antibiotics and their efficiency in treating infections, phage therapy fell into disuse. However, phage therapy has now re-emerged as an alternative for combating multidrug-resistant bacteria. The relationship between phages, bacteria, and the immune system is unique, generating a wide range of opportunities, some of which have yet to be studied. Thus, the objective of this review was to analyze the use of bacteriophages in the control of bovine mastitis and its association with other natural products today. Phages have been shown to exert effective antibacterial and anti-biofilm activity, and their interactions with other substances of natural origin could be a viable path for treating disease. Despite being little explored, phages are already being considered as an alternative for treatment against the main bacterial agents of mastitis. In this review, the safety and future pathways of phage therapy are addressed in order to indicate points where research still needs to progress and the main advantages and difficulties in this area.
- 17 September 2020
- Published by Research, Society and Development in Research, Society and Development
- Vol. 9 (10)
Open AccessBacteriophages’ action against mastitis-causing bactéria
Mastitis is a breast tissue disease with a high incidence in dairy cows and implications ranging from the health of the animals to the economy of the sector. Although antibiotic therapy is widely used, the search for new perspectives in the management and treatment of this disease is necessary. Although phage research preceded the discovery of antibiotics, with the appearance of antibiotics and their efficiency in treating infections, phage therapy fell into disuse. However, phage therapy has now re-emerged as an alternative for combating multidrug-resistant bacteria. The relationship between phages, bacteria, and the immune system is unique, generating a wide range of opportunities, some of which have yet to be studied. Thus, the objective of this review was to analyze the use of bacteriophages in the control of bovine mastitis and its association with other natural products today. Phages have been shown to exert effective antibacterial and anti-biofilm activity, and their interactions with other substances of natural origin could be a viable path for treating disease. Despite being little explored, phages are already being considered as an alternative for treatment against the main bacterial agents of mastitis. In this review, the safety and future pathways of phage therapy are addressed in order to indicate points where research still needs to progress and the main advantages and difficulties in this area.
- Open Access
- 1 August 2020
- Published by FapUNIFESP (SciELO) in Arquivo Brasileiro de Medicina Veterinária e Zootecnia
- Vol. 72 (4) , 1441-1448
Eficácia da suplementação oral com 1,3-1,6 betaglucano proveniente de Saccharomyces cerevisiae no controle da mastite bovina
RESUMO A mastite bovina, uma das principais doenças do rebanho leiteiro, caracteriza-se por um processo inflamatório no úbere. A inviabilidade econômica, o impacto ambiental negativo e os resíduos antimicrobianos têm estimulado a pesquisa de outros tratamentos alternativos para a prevenção e o tratamento de doenças na bovinocultura leiteira. O betaglucano é um agente imunomodulador com potencial ação preventiva para doenças infecciosas, inclusive a mastite. Este estudo teve como objetivo avaliar a eficácia do uso do betaglucano, por meio de administração oral, em animais em lactação. Foram utilizadas 20 vacas lactantes, distribuídas em dois grupos, um controle e um tratamento, com 10 animais em cada grupo. O grupo tratamento recebeu 5g/dia, durante 60 dias, de 1,3-1,6 betaglucano isolado da parede celular de Saccharomyces cerevisiae diluído em ração após a ordenha, enquanto o grupo controle recebia somente a ração. Foram realizados os testes de California Mastitis Test (CMT), contagem de células somáticas (CCS), produção de leite e percentual de gordura e proteína no leite. Não houve diferença estatisticamente significativa entre os grupos quanto à CCS, ao CMT, à composição do leite ou produção. Não se observou, portanto, eficácia do uso do betaglucano purificado, administrado por via oral, no controle e na prevenção da mastite em vacas leiteiras, quando comparadas com o grupo controle. Atribuem-se esses resultados, principalmente, à degradação ruminal do produto testado. Sugerem-se, portanto, mais pesquisas utilizando o 1,3-1,6 betaglucano purificado de parede de S. cerevisiae por outras vias de administração, tais como intramamária e subcutânea.
- 1 August 2020
- Published by FapUNIFESP (SciELO) in Arquivo Brasileiro de Medicina Veterinária e Zootecnia
- Vol. 72 (4) , 1441-1448
Open AccessEficácia da suplementação oral com 1,3-1,6 betaglucano proveniente de Saccharomyces cerevisiae no controle da mastite bovina
RESUMO A mastite bovina, uma das principais doenças do rebanho leiteiro, caracteriza-se por um processo inflamatório no úbere. A inviabilidade econômica, o impacto ambiental negativo e os resíduos antimicrobianos têm estimulado a pesquisa de outros tratamentos alternativos para a prevenção e o tratamento de doenças na bovinocultura leiteira. O betaglucano é um agente imunomodulador com potencial ação preventiva para doenças infecciosas, inclusive a mastite. Este estudo teve como objetivo avaliar a eficácia do uso do betaglucano, por meio de administração oral, em animais em lactação. Foram utilizadas 20 vacas lactantes, distribuídas em dois grupos, um controle e um tratamento, com 10 animais em cada grupo. O grupo tratamento recebeu 5g/dia, durante 60 dias, de 1,3-1,6 betaglucano isolado da parede celular de Saccharomyces cerevisiae diluído em ração após a ordenha, enquanto o grupo controle recebia somente a ração. Foram realizados os testes de California Mastitis Test (CMT), contagem de células somáticas (CCS), produção de leite e percentual de gordura e proteína no leite. Não houve diferença estatisticamente significativa entre os grupos quanto à CCS, ao CMT, à composição do leite ou produção. Não se observou, portanto, eficácia do uso do betaglucano purificado, administrado por via oral, no controle e na prevenção da mastite em vacas leiteiras, quando comparadas com o grupo controle. Atribuem-se esses resultados, principalmente, à degradação ruminal do produto testado. Sugerem-se, portanto, mais pesquisas utilizando o 1,3-1,6 betaglucano purificado de parede de S. cerevisiae por outras vias de administração, tais como intramamária e subcutânea.